Skip to content

Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock

Changes in Ventriculo-arterial Coupling and Myocardial Work During Treatment of Sepsis and Septic Shock: a Prospective Interventional Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06853574
Enrollment
30
Registered
2025-03-03
Start date
2025-02-28
Completion date
2025-06-30
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Septic Shock

Keywords

sepsis, septic shock, myocardial work, ventriculo-arterial coupling, ICU, intensive care

Brief summary

Sepsis is a term which describes an excessive response of the body to an infection and, if not promptly treated, can turn into septic shock a condition in which the organs don't receive enough oxygen to satisfy their needs. The aim of the study is to assess how the treatment of sepsis and septic shock will modify myocardial work and ventriculo-arterial coupling, that can be considered as indicators of ventricular and arterial performance efficacy respectively. Each patient will be treated according to updated guidelines for sepsis and septic shock management, they will voluntarily be enrolled and they can decide to withdraw in each moment without any consequence on their treatment. The investigators, after receiving the consent, will collect patients' data, take blood samples and perform ultrasound measurements and then will start the treatment which can be based on fluids infusion, vasopressors or both. The investigators think that a modern cardiovascular assessment approach can be used to individually set the optimal blood pressure target in sepsis and septic shock with the combined evaluation of myocardial work and ventriculo-arterial coupling.

Interventions

DRUGFluid therapy

Infusion of 8 ml/Kg/30' or 16 ml/kg/60' of fluids.

dosage will be titrated in order to obtain mean arterial pressure target

Sponsors

General and Teaching Hospital Celje
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 or more years old * sepsis * septic shock

Exclusion criteria

* lack of consent * less than 18 years old * pregnancy * more than moderate aortic stenosis ( aortic valve area (AVA) \< 1.4 cm2, aortic valve area indexed (AVAi) \< 0.85, doppler velocity index (DVI) \< 0.5) * more than mild mitral regurgitation (vena contracta (VC) width \<= 3 mm, mitral regurgitation (MR) effective regurgitant orifice area (EROA) \< 20, MR regurgitant volume (RegV) \< 30 ml) * cardiac arrythmias (e.g. atrial fibrillation/flutter, frequent ventricular and supraventricular or nodal activity) * renal replacement therapy * other than continous modes of mechanical ventilation

Design outcomes

Primary

MeasureTime frameDescription
Changes in ventriculo-arterial couplingFrom enrollment to 24 hours after treatment startventricular coupling will be analyzed on admission and its changes after treatment will be observed. To analyze ventriculo-arterial coupling, invasive blood pressure through either a radial or femoral arterial line will be collected and then data will be plotted into iElastance app available on smartphones to get the also knows as single beat determination ventriculo-arterial coupling.
Changes in myocardial workFrom enrollment to 24 hours after treatment startMyocardial work will be analyzed on admission and its changes after treatment will be observed. To realize this, a transthoracic cardiac ultrasound will be performed and the images will be transferred to EchoPAC from General Electrics (GE) to get the pressure-volume strain analysis also known as myocardial work.

Secondary

MeasureTime frameDescription
Mean arterial pressure optimal targetFrom enrollment to 24 hours after treatment startThe study aims to identify the optimal mean arterial pressure (MAP) target in sepsis and septic shock with the combined evaluation of myocardial work and ventriculo-arterial coupling. To realize this, invasive blood pressure through either a radial or femoral arterial line will be collected and then data will be plotted into iElastance app available on smartphones to get the also knows as single beat determination ventriculo-arterial coupling.

Countries

Slovenia

Contacts

Primary ContactMatej Prof. Dr. Podbregar, Intensive care medicine
podbregar.matej@gmail.com+38640215960
Backup ContactAndrea Dr. D'Angelo, Emergency medicine resident
andrea.dangelo.1092@gmail.com+393313550085

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026